Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Endotronix gets $45mm via Series D round

Executive Summary

Endotronix Inc. (devices for heart failure) raised $45mm in its Series D financing led by LSP, which adds a board member and was joined by Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, Wanxiang Healthcare Investments, and an unnamed corporate strategic investor. The company will use the proceeds to commercialize its Cordella heart failure system and for ongoing development of the Cordella pulmonary artery sensor and to bring it through CE Marking and FDA premarket approval.
Deal Industry
  • Digital Health
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies